Ngwenyama, N., Kirabo, A., Aronovitz, M., Velázquez, F., Carrillo-Salinas, F., Salvador, A. M., . . . Alcaide, P. (2021). Isolevuglandin-modified Cardiac Proteins Drive CD4+ T Cell Activation in the Heart and Promote Cardiac Dysfunction. Circulation.
Citación estilo ChicagoNgwenyama, Njabulo, et al. "Isolevuglandin-modified Cardiac Proteins Drive CD4+ T Cell Activation in the Heart and Promote Cardiac Dysfunction." Circulation 2021.
Cita MLANgwenyama, Njabulo, et al. "Isolevuglandin-modified Cardiac Proteins Drive CD4+ T Cell Activation in the Heart and Promote Cardiac Dysfunction." Circulation 2021.
Precaución: Estas citas no son 100% exactas.